Mechanisms of photocarcinogenesis in geriatric skin

老年皮肤光致癌机制

基本信息

  • 批准号:
    8532899
  • 负责人:
  • 金额:
    $ 33.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-01 至 2017-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Non-melanoma skin cancer (NMSC) has the highest incidence of all cancers in the United States. While rarely fatal, the treatment of NMSC is estimated to cost our healthcare system over a billion dollars annually. Therefore, the prevention rather than the excision of NMSC has the potential to have a major impact on healthcare costs. While it is clear that exposure to the ultraviolet components in sunlight (specifically UVB) can initiate and promote the development of NMSC, the reasons why some individuals develop skin cancer and survival of keratinocytes at the cost of replicative potential, i.e. keratinocytes become senescent. Absence of IGF-1 receptor activation, keratinocytes are more sensitive to UVB-induced apoptosis, but the keratinocytes that do survive retain the capacity to proliferate, an inappropriate UVB response. In vivo, we have demonstrated that keratinocytes in young skin respond appropriately to UVB exposure; however, a surprisingly high percentage of keratinocytes in geriatric skin respond inappropriately to UVB irradiation. We hypothesize that this inappropriate response to UVB irradiation in geriatric skin could lead to initiated carcinogenic keratinocytes. Furthermore, the inappropriate UVB response in geriatric keratinocytes is due to the silencing of IGF-1 expression (and corresponding inactivation of the IGF-1 receptor) in geriatric skin. Finally, we have shown that treatment of geriatric skin with ablative dermal rejuvenation therapies can re- establish youthful IGF-1 levels and subsequently reinstate the appropriate UVB response on sun-protected skin. In this proposal, we will expand our studies linking the susceptibility of geriatric skin to UVB-induced cancer to the IGF-1/IGF-1R signaling pathway. Although skin cancer can occur at any age, there is a strong correlation between the development of skin cancer and advancing age. In fact, the majority of skin cancers are found in people over the age of 60; therefore, age is also a risk factor for the development of skin cancer. Using data derived from recent in vitro, in vivo, and epidemiological data, we have demonstrated that aberrations in insulin-like growth factor-1 (IGF-1)/IGF-1 receptor signaling in geriatric skin contributes to their enhanced susceptibility to develop NMSC. In vitro, activation of the IGF-1 receptor regulates the response of normal human keratinocytes to UVB irradiation others do not are not fully understood. The IGF-1 receptor-dependent UVB response results in enhanced In the First, we will determine whether dermal rejuvenation therapies on geriatric skin will increase IGF-1 levels and correct the inappropriate UVB response for extended periods of time. Second, using human skin grafted onto immunodeficient mice we will mechanistically link the IGF-1 receptor-dependent inappropriate response to increased development of actinic neoplasia. Finally, mechanistic studies will examine elements of the IGF-1R signaling pathway in keratinocytes using UVB- irradiated human skin in vitro and in vivo. The successful completion of these specific aims will provide a direct link between the inappropriate UVB response in geriatric skin and the development of NMSC in geriatric patients. Furthermore, we will continue to evaluate the utility of prophylactic therapies that can prevent the occurrence of aging-associated photocarcinogenesis.
描述(申请人提供):非黑色素瘤皮肤癌(NMSC)是美国所有癌症中发病率最高的。虽然NMSC很少致命,但据估计,NMSC的治疗每年花费我们的医疗系统超过10亿美元。因此,预防而不是切除NMSC有可能对医疗成本产生重大影响。虽然暴露在阳光下的紫外线成分(特别是UVB)可以启动和促进NMSC的发展,但一些人患皮肤癌和角质形成细胞存活的原因是以复制能力为代价的, 即角质形成细胞变得衰老。没有IGF-1受体的激活,角质形成细胞对UVB诱导的凋亡更敏感,但存活的角质形成细胞保留了增殖的能力,这是一种不适当的UVB反应。在活体中,我们已经证明年轻皮肤中的角质形成细胞对UVB照射有适当的反应;然而,令人惊讶的是,老年人皮肤中有高比例的角质形成细胞对UVB照射有不适当的反应。我们推测,老年人皮肤对UVB辐射的这种不适当反应可能导致启动致癌角质形成细胞。此外,老年角质形成细胞对UVB的不适当反应是由于老年皮肤中IGF-1表达的沉默(以及相应的IGF-1受体失活)所致。最后,我们已经证明,用消融性真皮嫩肤疗法治疗老年皮肤可以恢复年轻的IGF-1水平,随后在防晒皮肤上恢复适当的UVB反应。在这项提案中,我们将扩展我们的研究,将老年皮肤对UVB诱导的癌症的易感性与IGF-1/IGF-1R信号通路联系起来。尽管皮肤癌可能发生在任何年龄,但皮肤癌的发展与年龄的增长之间存在很强的相关性。事实上,皮肤癌大多数发现于60岁以上的人;因此,年龄也是皮肤癌发生的风险因素。利用最近的体外、体内和流行病学数据,我们已经证明了老年皮肤中胰岛素样生长因子-1(IGF-1)/IGF-1受体信号的异常导致了他们对NMSC的易感性增加。在体外,IGF-1受体的激活调节正常人角质形成细胞对UVB辐射的反应,其他尚不完全清楚。IGF-1受体依赖的UVB反应增强首先,我们将确定老年皮肤的真皮嫩肤疗法是否会在较长时间内提高IGF-1水平并纠正不适当的UVB反应。第二,使用人皮肤移植到免疫缺陷小鼠身上,我们将从机械上将依赖于IGF-1受体的不恰当反应与光化性肿瘤的增加发展联系起来。最后,机制研究将在体外和体内使用UVB辐射的人皮肤来检测角质形成细胞中IGF-1R信号通路的元件。这些特定目标的成功完成将在老年皮肤中不适当的UVB反应与老年患者NMSC的发展之间提供直接联系。此外,我们将继续评估预防性治疗的有效性,以防止与衰老相关的光癌的发生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAN F SPANDAU其他文献

DAN F SPANDAU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAN F SPANDAU', 18)}}的其他基金

Regulation of cutaneous wound healing by GCN2
GCN2 对皮肤伤口愈合的调节
  • 批准号:
    10417023
  • 财政年份:
    2020
  • 资助金额:
    $ 33.41万
  • 项目类别:
Regulation of cutaneous wound healing by GCN2
GCN2 对皮肤伤口愈合的调节
  • 批准号:
    10651695
  • 财政年份:
    2020
  • 资助金额:
    $ 33.41万
  • 项目类别:
Regulation of cutaneous wound healing by GCN2
GCN2 对皮肤伤口愈合的调节
  • 批准号:
    9891914
  • 财政年份:
    2020
  • 资助金额:
    $ 33.41万
  • 项目类别:
Wounding therapy and photocarcinogenesis
创伤治疗和光致癌
  • 批准号:
    8783059
  • 财政年份:
    2014
  • 资助金额:
    $ 33.41万
  • 项目类别:
Wounding therapy and photocarcinogenesis
创伤治疗和光致癌
  • 批准号:
    9185418
  • 财政年份:
    2014
  • 资助金额:
    $ 33.41万
  • 项目类别:
Wounding Therapy and Photocarcinogenesis
创伤治疗和光致癌
  • 批准号:
    10704206
  • 财政年份:
    2014
  • 资助金额:
    $ 33.41万
  • 项目类别:
Mechanisms of photocarcinogenesis in geriatric skin
老年皮肤光致癌机制
  • 批准号:
    8371726
  • 财政年份:
    2012
  • 资助金额:
    $ 33.41万
  • 项目类别:
Mechanisms of photocarcinogenesis in geriatric skin
老年皮肤光致癌机制
  • 批准号:
    9064190
  • 财政年份:
    2012
  • 资助金额:
    $ 33.41万
  • 项目类别:
Role of senescent fibroblasts in UVB-induced carcinogenesis
衰老成纤维细胞在 UVB 诱导的癌发生中的作用
  • 批准号:
    7753681
  • 财政年份:
    2009
  • 资助金额:
    $ 33.41万
  • 项目类别:
Role of senescent fibroblasts in UVB-induced carcinogenesis
衰老成纤维细胞在 UVB 诱导的癌发生中的作用
  • 批准号:
    7589456
  • 财政年份:
    2009
  • 资助金额:
    $ 33.41万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 33.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    $ 33.41万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    $ 33.41万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    $ 33.41万
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    $ 33.41万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 33.41万
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    $ 33.41万
  • 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    $ 33.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    $ 33.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    $ 33.41万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了